The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated earnings power and cash flow generation. The investment bank said it has ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy recommendation. Analyst Price Forecast Suggests 35.56% Upside As of ...

The analyst is optimistic about Orthofix Medical's unique offerings and plans for ongoing innovation. 7D and ortho sub-segments are in Orthofix Medical's highest growing markets. Canaccord Genuity ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. The most recent guidance for Orthofix ...

Presents Shares and Regional Growth Trends for Cortical, Cancellous, and Hybrid Screws Segmented by Application and End Use PEEK Surgical Screws Market PEEK Surgical Screws Market Dublin, Feb. 07, ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...